Decades of Innovation,

Delivered in Months

The most advanced biolabs in space,

bringing breakthroughs in medicine and materials to market faster than anyone else

Helogen is a space biology company

bringing breakthroughs in medicine and materials to market faster than anyone else.

Our Partners

Memorial Sloan Kettering

Our partnership with MSK is focused on groundbreaking oncology drug development. We’re conducting in-orbit high throughput screening to accelerate advancements in cancer prevention.

NASA

We’re working with NASA on real-time RNA sequencing with our Gene Sequencer, advancing autonomous genetics research that will help humans live healthier lives in space. 

AgResearch

Together with AgResearch, New Zealand we’re advancing the in-space manufacturing of biocompatible polymers that will unlock novel applications in space and on planet Earth.

Our Partners

Memorial Sloan Kettering

Our partnership with MSK is focused on groundbreaking oncology drug development. We’re conducting in-orbit high throughput screening to accelerate advancements in cancer prevention.

Memorial Sloan Kettering

NASA

AgResearch

Core capabilities.

Core capabilities.

High-Throughput Screening & Drug Discovery

Oncology & Late-Onset Disease

Biopolymer & Engineered Biology

High-Throughput Screening & Drug Discovery

Achieve higher fidelity compound screening through the development of more physiologically relevant tissue models. Helogen’s cutting-edge instrumentation, including the Multi-Modal Culture Analyzer, Sequencer, and Bioreactor, lets you accelerate your pipeline by driving new target discovery, leveraging complex disease modeling and expediting compound testing through high-throughput screening. We harness the unique conditions of space to optimize your drug development process, helping you transform breakthroughs into market-ready therapeutics.

High-Throughput Screening & Drug Discovery

Oncology & Late-Onset Disease

Biopolymer & Engineered Biology

High-Throughput Screening & Drug Discovery

Achieve higher fidelity compound screening through the development of more physiologically relevant tissue models. Helogen’s cutting-edge instrumentation, including the Multi-Modal Culture Analyzer, Sequencer, and Bioreactor, lets you accelerate your pipeline by driving new target discovery, leveraging complex disease modeling and expediting compound testing through high-throughput screening. We harness the unique conditions of space to optimize your drug development process, helping you transform breakthroughs into market-ready therapeutics.

Experience the speed of light,

for your research team.

Experience the speed of light,

for your research team.

Upcoming missions

Upcoming missions

HC-252-Conan

launch schedule

HC-252-Conan

Nov 2025

Drug Development Mission – Radiation mitigation and oncology drug development using Helogen's Multi-Modal Culture Sequencer (MCS).

HC-263-Cyrus

Mar 2026

Life Sciences Mission – High-throughput screening drug development, in space manufacturing, and more using Helogen’s MCS and Multi-Modal Culture Analyzer (MCA).

HC-264-TBD

Jun 2026

Life Sciences Mission – To be announced soon.

HC-252-Conan

launch schedule

HC-252-Conan

Nov 2025

Drug Development Mission – Radiation mitigation and oncology drug development using Helogen's Multi-Modal Culture Sequencer (MCS).

HC-263-Cyrus

Mar 2026

Life Sciences Mission – High-throughput screening drug development, in space manufacturing, and more using Helogen’s MCS and Multi-Modal Culture Analyzer (MCA).

HC-264-TBD

Jun 2026

Life Sciences Mission – To be announced soon.

Get your competitive edge
in space today.

Get your competitive edge
in space today.

Helogen leverages space to accelerate biological processes and fast-track breakthroughs in healthcare, wellness, and cosmetics — getting your products to market faster than ever.

Copyright © 2025 Helogen, Inc.

Copyright © 2025 Helogen, Inc.